Clinical Trial Update: Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing nemonoxacin to levofloxacin in adults with community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Nemonoxacin (Nemonoxacin)

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Community-Acquired Pneumonia | Phase 2 | Status: COMPLETED